Challenges & Opportunities for Imaging & Biomarker Endpoints that Reveal Cardiac & Vascular Remodeling

Time: 3:30 pm
day: Conference Day 2


  • Adapting cardiovascular imaging from their diagnostic application into drug development tools can serve multiple biomarker roles (efficacy, selection, safety)
  • Myocardial structure and function endpoints can elucidate therapeutic response if appropriately selected
  • Innovation with these techniques and in combination with peripheral biomarkers will have a role in cardiovascular precision medicine